Neuropilin functions as an essential cell surface receptor

Journal of Biological Chemistry

Volumn 290, Issue 49, 2015, Pages 29120-29126

  Guo, Hou Fu ^a   Vander Kooi, Craig W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CROSSTALK;

ANGIOGENESIS; AXON GUIDANCES; CELL SURFACE RECEPTORS; CORECEPTORS; HUMAN HEALTH; NEUROPILINS; PHYSIOLOGICAL PROCESS;

CELL SIGNALING;

ARGININE; CELL SURFACE RECEPTOR; FURIN; GLYCOSAMINOGLYCAN; INTEGRIN; NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; SEMAPHORIN; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; LIGAND; PROTEIN BINDING; VASCULOTROPIN A;

ANGIOGENESIS; CELL ADHESION; CELL INTERACTION; ENDOCYTOSIS; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; INTERNALIZATION; INTRACELLULAR SIGNALING; LIGAND BINDING; LYMPHANGIOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS ENTRY; ANIMAL; AXON; CELL MEMBRANE; METABOLISM; MOUSE; PHENOTYPE; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; AXONS; CELL ADHESION; CELL MEMBRANE; HUMANS; LIGANDS; MICE; NEUROPILINS; PHENOTYPE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SEMAPHORINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84949009163     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R115.687327     Document Type: Review

References (100)

1. Parker, M. W., Guo, H. F., Li, X., Linkugel, A. D., and Vander Kooi, C. W. (2012) Function of members of the neuropilin family as essential pleiotropic cell surface receptors. Biochemistry 51, 9437-9446
2. Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., and Fujisawa, H. (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895-4902
3. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., and Fujisawa, H. (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121, 4309-4318
4. Li, X., Parker, M. W., and Vander Kooi, C. W. (2014) Control of cellular motility by neuropilin-mediated physical interactions. Biomol. Concepts 5, 157-166
5. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439
6. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442
7. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66
8. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745
9. Jones, E. A., Yuan, L., Breant, C., Watts, R. J., and Eichmann, A. (2008) Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development 135, 2479-2488
10. Fantin, A., Vieira, J. M., Plein, A., Denti, L., Fruttiger, M., Pollard, J. W., and Ruhrberg, C. (2013) NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 121, 2352-2362
11. Aspalter, I. M., Gordon, E., Dubrac, A., Ragab, A., Narloch, J., Vizán, P., Geudens, I., Collins, R. T., Franco, C. A., Abrahams, C. L., Thurston, G., Fruttiger, M., Rosewell, I., Eichmann, A., and Gerhardt, H. (2015) Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nat. Commun. 6, 7264
12. Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., and Eichmann, A. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806
13. Kärpänen, T., Heckman, C. A., Keskitalo, S., Jeltsch, M., Ollila, H., Neufeld, G., Tamagnone, L., and Alitalo, K. (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472
14. Caunt, M., Mak, J., Liang, W. C., Stawicki, S., Pan, Q., Tong, R. K., Kowalski, J., Ho, C., Reslan, H. B., Ross, J., Berry, L., Kasman, I., Zlot, C., Cheng, Z., Le Couter, J., Filvaroff, E. H., Plowman, G., Peale, F., French, D., Carano, R., Koch, A. W., Wu, Y., Watts, R. J., Tessier-Lavigne, M., and Bagri, A. (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13, 331-342
15. Xu, Y., Yuan, L., Mak, J., Pardanaud, L., Caunt, M., Kasman, I., Larrivée, B., Del Toro, R., Suchting, S., Medvinsky, A., Silva, J., Yang, J., Thomas, J. L., Koch, A. W., Alitalo, K., Eichmann, A., and Bagri, A. (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115-130
16. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki Ji, J., Hirota, S., Kitamura, Y., Kitsukawa, T., Fujisawa, H., Klagsbrun, M., and Hori, M. (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 99, 3657-3662
17. Pan, Q., Chathery, Y., Wu, Y., Rathore, N., Tong, R. K., Peale, F., Bagri, A., Tessier-Lavigne, M., Koch, A. W., and Watts, R. J. (2007) Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 282, 24049-24056
18. Parker, M. W., Xu, P., Li, X., and Vander Kooi, C. W. (2012) Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J. Biol. Chem. 287, 11082-11089
19. Parker, M. W., Xu, P., Guo, H. F., and Vander Kooi, C. W. (2012) Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition. PLoS ONE 7, e49177
20. Bates, D. O., Cui, T. G., Doughty, J. M., Winkler, M., Sugiono, M., Shields, J. D., Peat, D., Gillatt, D., and Harper, S. J. (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62, 4123-4131
21. Parker, M. W., Linkugel, A. D., Goel, H. L., Wu, T., Mercurio, A. M., and Vander Kooi, C. W. (2015) Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form. Structure 23, 677-687
22. Yao, X., and Bouyain, S. (2015) Splicing and proteolytic processing in VEGF signaling: now it is the coreceptor's turn. Structure 23, 610-611
23. Dijkstra, M. H., Pirinen, E., Huusko, J., Kivelä, R., Schenkwein, D., Alitalo, K., and Ylä-Herttuala, S. (2014) Lack of cardiac and high-fat diet induced metabolic phenotypes in two independent strains of Vegf-b knockout mice. Sci. Rep. 4, 6238
24. Hagberg, C. E., Mehlem, A., Falkevall, A., Muhl, L., Fam, B. C., Ortsäter, H., Scotney, P., Nyqvist, D., Samén, E., Lu, L., Stone-Elander, S., Proietto, J., Andrikopoulos, S., Sjöholm, A., Nash, A., and Eriksson, U. (2012) Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature 490, 426-430
25. von Wronski, M. A., Raju, N., Pillai, R., Bogdan, N. J., Marinelli, E. R., Nanjappan, P., Ramalingam, K., Arunachalam, T., Eaton, S., Linder, K. E., Yan, F., Pochon, S., Tweedle, M. F., and Nunn, A. D. (2006) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J. Biol. Chem. 281, 5702-5710
26. Starzec, A., Vassy, R., Martin, A., Lecouvey, M., Di Benedetto, M., Crépin, M., and Perret, G. Y. (2006) Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sci. 79, 2370-2381
27. Jia, H., Bagherzadeh, A., Hartzoulakis, B., Jarvis, A., Löhr, M., Shaikh, S., Aqil, R., Cheng, L., Tickner, M., Esposito, D., Harris, R., Driscoll, P. C., Selwood, D. L., and Zachary, I. C. (2006) Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J. Biol. Chem. 281, 13493-13502
28. Teesalu, T., Sugahara, K. N., Kotamraju, V. R., and Ruoslahti, E. (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. U.S.A. 106, 16157-16162
29. Parker, M. W., Hellman, L. M., Xu, P., Fried, M. G., and Vander Kooi, C. W. (2010) Furin processing of semaphorin 3F determines its antiangiogenic activity by regulating direct binding and competition for neuropilin. Biochemistry 49, 4068-4075
30. Vander Kooi, C. W., Jusino, M. A., Perman, B., Neau, D. B., Bellamy, H. D., and Leahy, D. J. (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl. Acad. Sci. U.S.A. 104, 6152-6157
31. Teesalu, T., Sugahara, K. N., and Ruoslahti, E. (2012) Mapping of vascular ZIP codes by phage display. Methods Enzymol. 503, 35-56
32. Pang, H. B., Braun, G. B., Friman, T., Aza-Blanc, P., Ruidiaz, M. E., Sugahara, K. N., Teesalu, T., and Ruoslahti, E. (2014) An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nat. Commun. 5, 4904
33. Gelfand, M. V., Hagan, N., Tata, A., Oh, W. J., Lacoste, B., Kang, K. T., Kopycinska, J., Bischoff, J., Wang, J. H., and Gu, C. (2014) Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding. Elife 3, e03720
34. Fuh, G., Garcia, K. C., and de Vos, A. M. (2000) The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1. J. Biol. Chem. 275, 26690-26695
35. Krilleke, D., DeErkenez, A., Schubert, W., Giri, I., Robinson, G. S., Ng, Y. S., and Shima, D. T. (2007) Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 282, 28045-28056
36. Uniewicz, K. A., Ori, A., Ahmed, Y. A., Yates, E. A., and Fernig, D. G. (2014) Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars. PeerJ 2, e461
37. Teran, M., and Nugent, M. A. (2015) Synergistic Binding of vascular endothelial growth factor-A and its receptors to heparin selectively modulates complex affinity. J. Biol. Chem. 290, 16451-16462
38. Shintani, Y., Takashima, S., Asano, Y., Kato, H., Liao, Y., Yamazaki, S., Tsukamoto, O., Seguchi, O., Yamamoto, H., Fukushima, T., Sugahara, K. Kitakaze, M., and Hori, M. (2006) Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25, 3045-3055
39. Hota, P. K., and Buck, M. (2012) Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions. Cell. Mol. Life Sci. 69, 3765-3805
40. Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D., and Kolodkin, A. L. (2002) Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J. Biol. Chem. 277, 18069-18076
41. Merte, J., Wang, Q., Vander Kooi, C. W., Sarsfield, S., Leahy, D. J., Kolodkin, A. L., and Ginty, D. D. (2010) A forward genetic screen in mice identifies Sema3AK108N, which binds to neuropilin-1 but cannot signal. J. Neurosci. 30, 5767-5775
42. Janssen, B. J., Malinauskas, T., Weir, G. A., Cader, M. Z., Siebold, C., and Jones, E. Y. (2012) Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex. Nat. Struct. Mol. Biol. 19, 1293-1299
43. Adams, R. H., Lohrum, M., Klostermann, A., Betz, H., and Püschel, A. W. (1997) The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 16, 6077-6086
44. Hanchate, N. K., Giacobini, P., Lhuillier, P., Parkash, J., Espy, C., Fouveaut, C., Leroy, C., Baron, S., Campagne, C., Vanacker, C., Collier, F., Cruaud, C., Meyer, V., García-Piñero, A., Dewailly, D., Cortet-Rudelli, C., Gersak, K., Metz, C., Chabrier, G., Pugeat, M., Young, J., Hardelin, J. P., Prevot, V., and Dodé, C. (2012) SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet. 8, e1002896
45. Delgoffe, G. M., Woo, S. R., Turnis, M. E., Gravano, D. M., Guy, C., Overacre, A. E., Bettini, M. L., Vogel, P., Finkelstein, D., Bonnevier, J., Workman, C. J., and Vignali, D. A. (2013) Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501, 252-256
46. Yang, W. J., Hu, J., Uemura, A., Tetzlaff, F., Augustin, H. G., and Fischer, A. (2015) Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol. Med. 7, 1267-1284
47. Nakayama, H., Bruneau, S., Kochupurakkal, N., Coma, S., Briscoe, D. M., and Klagsbrun, M. (2015) Regulation of mTOR signaling by Semaphorin 3F-Neuropilin 2 interactions in vitro and in vivo. Sci. Rep. 5, 11789
48. Mumblat, Y., Kessler, O., Ilan, N., and Neufeld, G. (2015) Full-Length Semaphorin-3C is an inhibitor of tumor lymphangiogenesis and metastasis. Cancer Res. 75, 2177-2186
49. Gu, C., Rodriguez, E. R., Reimert, D. V., Shu, T., Fritzsch, B., Richards, L. J., Kolodkin, A. L., and Ginty, D. D. (2003) Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell 5, 45-57
50. Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., Tessier-Lavigne, M., Taniguchi, M., Püschel, A. W., and Bussolino, F. (2003) Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391-397
51. Tamagnone, L., and Mazzone, M. (2011) Semaphorin signals on the road of endothelial tip cells. Dev. Cell 21, 189-190
52. Guo, H. F., Li, X., Parker, M. W., Waltenberger, J., Becker, P. M., and Vander Kooi, C. W. (2013) Mechanistic basis for the potent anti-angiogenic activity of Semaphorin 3F. Biochemistry 52, 7551-7558
53. Parker, M. W., Linkugel, A. D., and Vander Kooi, C. W. (2013) Effect of C-terminal sequence on competitive Semaphorin binding to Neuropilin-1. J. Mol. Biol. J. Mol. Biol. 425, 4405-4414
54. Bachelder, R. E., Lipscomb, E. A., Lin, X., Wendt, M. A., Chadborn, N. H., Eickholt, B. J., and Mercurio, A. M. (2003) Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63, 5230-5233
55. Bender, R. J., and Mac Gabhann, F. (2013) Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer. PLoS ONE 8, e61788
56. Ghez, D., Lepelletier, Y., Lambert, S., Fourneau, J. M., Blot, V., Janvier, S., Arnulf, B., van Endert, P. M., Heveker, N., Pique, C., and Hermine, O. (2006) Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80, 6844-6854
57. Lambert, S., Bouttier, M., Vassy, R., Seigneuret, M., Petrow-Sadowski, C., Janvier, S., Heveker, N., Ruscetti, F. W., Perret, G., Jones, K. S., and Pique, C. (2009) HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood 113, 5176-5185
58. Wang, H. B., Zhang, H., Zhang, J. P., Li, Y., Zhao, B., Feng, G. K., Du, Y., Xiong, D., Zhong, Q., Liu, W. L., Du, H., Li, M. Z., Huang, W. L., Tsao, S. W., Hutt-Fletcher, L., Zeng, Y. X., Kieff, E., and Zeng, M. S. (2015) Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat. Commun. 6, 6240
59. Yamada, Y., Takakura, N., Yasue, H., Ogawa, H., Fujisawa, H., and Suda, T. (2001) Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood 97, 1671-1678
60. Uniewicz, K. A., Cross, M. J., and Fernig, D. G. (2011) Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. J. Biol. Chem. 286, 12-23
61. Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H. Q., Takashima, S., Soker, S., and Klagsbrun, M. (2000) Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc. Natl. Acad. Sci. U.S.A. 97, 2573-2578
62. Rossignol, M., Gagnon, M. L., and Klagsbrun, M. (2000) Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70, 211-222
63. Schuch, G., Machluf, M., Bartsch, G., Jr., Nomi, M., Richard, H., Atala, A., and Soker, S. (2002) In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100, 4622-4628
64. Swendeman, S., Mendelson, K., Weskamp, G., Horiuchi, K., Deutsch, U., Scherle, P., Hooper, A., Rafii, S., and Blobel, C. P. (2008) VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ. Res. 103, 916-918
65. Yang, S., Cheng, H., Huang, Z., Wang, X., Wan, Y., Cai, J., and Wang, Z. (2015) Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker. Dis. Markers 2015, 506428
66. Fantin, A., Schwarz, Q., Davidson, K., Normando, E. M., Denti, L., and Ruhrberg, C. (2011) The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins. Development 138, 4185-4191
67. Lanahan, A., Zhang, X., Fantin, A., Zhuang, Z., Rivera-Molina, F., Speichinger, K., Prahst, C., Zhang, J., Wang, Y., Davis, G., Toomre, D., Ruhrberg, C., and Simons, M. (2013) The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev. Cell 25, 156-168
68. Cai, H., and Reed, R. R. (1999) Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J. Neurosci. 19, 6519-6527
69. Wang, L., Mukhopadhyay, D., and Xu, X. (2006) C terminus of RGSGAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J. 20, 1513-1515
70. Chittenden, T. W., Claes, F., Lanahan, A. A., Autiero, M., Palac, R. T., Tkachenko, E. V., Elfenbein, A., Ruiz de Almodovar, C., Dedkov, E., Tomanek, R., Li, W., Westmore, M., Singh, J. P., Horowitz, A., Mulligan-Kehoe, M. J., Moodie, K. L., Zhuang, Z. W., Carmeliet, P., and Simons, M. (2006) Selective regulation of arterial branching morphogenesis by synectin. Dev. Cell 10, 783-795
71. Prahst, C., Héroult, M., Lanahan, A. A., Uziel, N., Kessler, O., Shraga-Heled, N., Simons, M., Neufeld, G., and Augustin, H. G. (2008) Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J. Biol. Chem. 283, 25110-25114
72. Valdembri, D., Caswell, P. T., Anderson, K. I., Schwarz, J. P., König, I., Astanina, E., Caccavari, F., Norman, J. C., Humphries, M. J., Bussolino, F., and Serini, G. (2009) Neuropilin-1/GIPC1 signaling regulatesα5β1 integrin traffic and function in endothelial cells. PLoS Biol. 7, e25
73. Berger, P., and Ballmer-Hofer, K. (2011) The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space. Swiss Med. Wkly. 141, w13318
74. Seerapu, H. R., Borthakur, S., Kong, N., Agrawal, S., Drazba, J., Vasanji, A., Fantin, A., Ruhrberg, C., Buck, M., and Horowitz, A. (2013) The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover. FEBS Lett. 587, 3392-3399
75. Reed, B. C., Cefalu, C., Bellaire, B. H., Cardelli, J. A., Louis, T., Salamon, J., Bloecher, M. A., and Bunn, R. C. (2005) GLUT1CBP(TIP2/GIPC1) interactions with GLUT1 and myosin VI: evidence supporting an adapter function for GLUT1CBP. Mol. Biol. Cell 16, 4183-4201
76. Naccache, S. N., Hasson, T., and Horowitz, A. (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles. Proc. Natl. Acad. Sci. U.S.A. 103, 12735-12740
77. Staton, C. A., Koay, I., Wu, J. M., Hoh, L., Reed, M. W., and Brown, N. J. (2013) Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer. Histopathology 62, 908-915
78. Yamada, Y., Oike, Y., Ogawa, H., Ito, Y., Fujisawa, H., Suda, T., and Takakura, N. (2003) Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood 101, 1801-1809
79. Koch, S., van Meeteren, L. A., Morin, E., Testini, C., Weström, S., Björkelund, H., Le Jan, S., Adler, J., Berger, P., and Claesson-Welsh, L. (2014) NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation. Dev. Cell 28, 633-646
80. Miao, H. Q., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. (2000) Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14, 2532-2539
81. Cao, Y., Hoeppner, L. H., Bach, S., Guangqi, E., Guo, Y., Wang, E., Wu, J., Cowley, M. J., Chang, D. K., Waddell, N., Grimmond, S. M., Biankin, A. V., Daly, R. J., Zhang, X., and Mukhopadhyay, D. (2013) Neuropilin-2 promotes extravasation and metastasis by interacting with endothelialα5 integrin. Cancer Res. 73, 4579-4590
82. Wang, L., Zeng, H., Wang, P., Soker, S., and Mukhopadhyay, D. (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J. Biol. Chem. 278, 48848-48860
83. Evans, I. M., Yamaji, M., Britton, G., Pellet-Many, C., Lockie, C., Zachary, I. C., and Frankel, P. (2011) Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Mol. Cell. Biol. 31, 1174-1185
84. Ou, J. J., Wei, X., Peng, Y., Zha, L., Zhou, R. B., Shi, H., Zhou, Q., and Liang, H. J. (2015) Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling. Cancer Lett. 358, 200-209
85. West, D. C., Rees, C. G., Duchesne, L., Patey, S. J., Terry, C. J., Turnbull, J. E., Delehedde, M., Heegaard, C. W., Allain, F., Vanpouille, C., Ron, D., and Fernig, D. G. (2005) Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J. Biol. Chem. 280, 13457-13464
86. Banerjee, S., Sengupta, K., Dhar, K., Mehta, S., D'Amore, P. A., Dhar, G., and Banerjee, S. K. (2006) Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol. Carcinog. 45, 871-880
87. Glinka, Y., and Prud'homme, G. J. (2008) Neuropilin-1 is a receptor for transforming growth factorβ-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310
88. Ellison, T. S., Atkinson, S. J., Steri, V., Kirkup, B. M., Preedy, M. E., Johnson, R. T., Ruhrberg, C., Edwards, D. R., Schneider, J. G., Weilbaecher, K., and Robinson, S. D. (2015) Suppressing ∼3-integrin triggers a neuropilin-1 dependent change in focal adhesion remodelling that can be targeted to block pathological angiogenesis. Dis. Model. Mech. 8, 1105-1119
89. Fukasawa, M., Matsushita, A., and Korc, M. (2007) Neuropilin-1 interacts with integrinβ1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol. Ther. 6, 1173-1180
90. Yaqoob, U., Cao, S., Shergill, U., Jagavelu, K., Geng, Z., Yin, M., de Assuncao, T. M., Cao, Y., Szabolcs, A., Thorgeirsson, S., Schwartz, M., Yang, J. D., Ehman, R., Roberts, L., Mukhopadhyay, D., and Shah, V. H. (2012) Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res. 72, 4047-4059
91. Goel, H. L., Pursell, B., Standley, C., Fogarty, K., and Mercurio, A. M. (2012) Neuropilin-2 regulatesα6β1 integrin in the formation of focal adhesions and signaling. J. Cell Sci. 125, 497-506
92. Goel, H. L., Pursell, B., Chang, C., Shaw, L. M., Mao, J., Simin, K., Kumar, P., Vander Kooi, C. W., Shultz, L. D., Greiner, D. L., Norum, J. H., Toftgard, R., Kuperwasser, C., and Mercurio, A. M. (2013) GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol. Med. 5, 488-508
93. Maric, G., Annis, M. G., Dong, Z., Rose, A. A., Ng, S., Perkins, D., Mac-Donald, P. A., Ouellet, V., Russo, C., and Siegel, P. M. (2015) GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrinα for efficient breast cancer metastasis. Oncogene 34, 5494-5504
94. Goel, H. L., Gritsko, T., Pursell, B., Chang, C., Shultz, L. D., Greiner, D. L., Norum, J. H., Toftgard, R., Shaw, L. M., and Mercurio, A. M. (2014) Regulated splicing of theα6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. Cell Rep. 7, 747-761
95. Robinson, S. D., Reynolds, L. E., Kostourou, V., Reynolds, A. R., da Silva, R. G., Tavora, B., Baker, M., Marshall, J. F., and Hodivala-Dilke, K. M. (2009)v ∼3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J. Biol. Chem. 284, 33966-33981
96. Raimondi, C., Fantin, A., Lampropoulou, A., Denti, L., Chikh, A., and Ruhrberg, C. (2014) Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. J. Exp. Med. 211, 1167-1183
97. Hochman, E., Castiel, A., Jacob-Hirsch, J., Amariglio, N., and Izraeli, S. (2006) Molecular pathways regulating pro-migratory effects of Hedgehog signaling. J. Biol. Chem. 281, 33860-33870
98. Hillman, R. T., Feng, B. Y., Ni, J., Woo, W. M., Milenkovic, L., Hayden Gephart, M. G., Teruel, M. N., Oro, A. E., Chen, J. K., and Scott, M. P. (2011) Neuropilins are positive regulators of Hedgehog signal transduction. Genes Dev. 25, 2333-2346
99. Cao, Y., Wang, L., Nandy, D., Zhang, Y., Basu, A., Radisky, D., and Mukhopadhyay, D. (2008) Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res. 68, 8667-8672
100. Hayden Gephart, M. G., Su, Y. S., Bandara, S., Tsai, F. C., Hong, J., Conley, N., Rayburn, H., Milenkovic, L., Meyer, T., and Scott, M. P. (2013) Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma. J. Neurooncol. 115, 161-168